Healthcare Big Data Analytics Market Growth, Share, Future Trends, Segmentation, Size Projection and Industry Outlook by 2027

 

Healthcare Big Data Analytics Market Overview

Big data is the large volume of unstructured data generated during business operations on a daily basis. Analytics involves processing of data by use of complex algorithms so as to find meaningful patterns from it. The global healthcare big data analytics market is anticipated to generate USD 9.5 billion in 2023 from USD 5.5 billion in 2016, at a CAGR of about 11.5 %.

Market Dynamics Drivers:

The applications of big data for healthcare includes differentiating pricing strategies and price optimization, search engine optimization (SEO), advanced forecasting of disease patterns, better sample selection in clinical trials, elucidation of benefits of therapy etc. It is estimated that worldwide digital healthcare data reached a quantum figure of around 500 petabytes in  2012 alone and which is anticipated to reach 25,000 petabytes by 2020. The opportunities include quantification of link between actions and revenues, greater market penetration, better customer targeting and engagement, economies of personalized medicine, real time data for feedback and brand equity, corrective actions for customer switching, greater product differentiation, not to mention better customer satisfaction.

High potential applications and opportunities of healthcare analytics are creating excitement for their rapid adoption and deployment. Prominent applications and opportunities are;

  • Right living- Targeted disease prevention and data-enabled adherence programs. For example informed lifestyle choices that promote wellbeing and the active engagement of consumers in their own care
  • Right care – Alignment around proven pathways and coordinated care across providers. For example personalized care. Asthmapolis has created a GPS-enabled tracker that monitors inhaler usage by asthmatics.
  • Right provider – Shifting volume to right care setting and reducing readmit rates. Integrating clinical and claims data enables provider with a complete picture. Thus patient switching costs and elimination of frauds can be achieved.
  • Right value – Payment innovation and alignment and provider-performance transparency. Sustainable approaches that continuously enhance healthcare value by reducing cost at the same or better quality. Thus penalties associated with readmission rates can be eliminated.
  • Right innovation - Accelerating discovery in R&D and improving trial operations.

Restraints

The market barriers involved are legal restrictions, data security, privacy concerns, problems with data collection and processing, integration of multi-point and multi-sectorial cross channel data etc. Traditionally, healthcare is segmented by product, by therapeutic application, by route of administration, by drug class, by end user etc. This approach has evolved over time but is constrained by fragmentation and does not reflect the changing scenario of healthcare industry such as personalized medicines, changing regulation etc. To overcome this barrier, integration of databases is essential.

Unstructured data refers to unstandardized data and accounts about 60% of the healthcare care information, which is a challenge.

Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/726

Segments:

The global healthcare big data analytics market is segmented by components, deployment type, application, software type, end users and regions

  • Components - Hardware and Software,
  • Deployment type - software on-premise and software on demand,
  • Application - clinical analytics, financial analytics, and operational analytics
  • Software type - practice management software, electronic health record software, workforce management software, revenue cycle management software, and others
  • End user - hospitals, clinics, diagnostic centers and others 
  • Regions - North America, Europe, Asia-Pacific and Middle East and Africa.

Regional Analysis:

North America led by the U.S. is the absolute leader for healthcare big data analytics market. North America is estimated to generate a CAGR of 6.1 % generating USD 4.25 billion. Antecedents for the growth in big data analytics in the U.S. healthcare industry are growing concerns of healthcare costs, establishment of healthcare policies favoring adoption of analytics by federal government, growing focus on big data management and analytics and technological advancement such as m-health and precision medicines.

Europe accounts for the second largest market with U.K. Germany, France and the Scandinavian nations of Norway, Finland and others leading the market. Presence of global players and excellent research ecology are prime drivers of the market.

The market is expected to shift its momentum in favor of Asia-Pacific, led by Japan, China, India and others. The Middle East and Africa region is expected to deliver a moderate growth skewed in favor of the Gulf economies of Saudi Arabia, UAE and others.

Key Players:

Some of the dominant players in the healthcare big data analytics market are IBM, GE Healthcare, Cerner Corporation, Philips, Dell, Epic System Corporation, McKesson, Cognizant, Optum, Siemens and others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/healthcare-big-data-analytics-market-726

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

 

 

Comments

Post a Comment

Popular posts from this blog

Asthma Inhaler Device market poised to achieve significant growth in the years to come

  Asthma Inhaler Device Market Overview The global asthma inhaler devices market is likely to expand at 5.2 % CAGR during the forecast period (2017-2022) owing to the increasing prevalence of asthma among the crowd, asserts Market Research Future (MRFR). An inflammatory disease of the lungs, asthma is characterized by the difficulty faced while breathing. The symptoms of asthma are often triggered with exposure to allergens such as ragweed, pollen, animal dander, and irritants such as chemical fumes and smoke. Asthma leads to swelling of the inside walls of an asthmatic’s airways and makes airways sensitive to irritations. Drivers and Constraints Impacting the Market With the increasing prevalence of asthma especially among the children, the market is likely to propel over the assessment period. For instance, around 9 million children under five years of age die every year due to the presence of lung diseases. The increasing disposable income and rising preference for combinati...
Read more

Surgical Drapes and Gowns Market Trends with worldwide Industry Analysis, Features, Top Player and Forecast 2030

Image
  Surgical Drapes and Gowns Market Overview The Global Surgical Drapes and Gowns anticipated to have held a market value of USD 2.23 billion in the year 2017 and is expected to grow at a CAGR of 4.4% during the forecast period. Surgical drapes and surgical gowns are used during surgery to maintain sterile surgical field and reduce the risk of contamination and prevention of surgical site infection. Surgical drapes and surgical gowns are used by patients and healthcare professional such as, nurses and doctors. Hospitals, clinics and ambulatory surgical centers are the major end user of the surgical drapes and surgical gowns products. Similarly, According to Public Health England, during 2016 to 2017 around 139,691 procedures were performed in NHS based hospitals in England and about 1,635 surgical site infections (SSIs) detected during the same period. Increasing number of surgeries in healthcare settings and high incidences of hospital-acquired infections are expec...
Read more

Blood Grouping Reagents Market is Expected to Grow at a CAGR of 7.74% by 2027

  Blood Grouping Reagents Market Overview The global blood grouping reagents market is expected to register a CAGR of   7.74%  during the forecast period and is expected to hit USD 2,642.17 million by 2027. Blood grouping reagents are solutions that can be used to determine ABO, Rhesus, Kell and MNS blood groups These classifications of human blood are all based on the presence or absence of certain antigens on the surface of red blood cells. The growth of the global blood grouping reagents market is expected to be driven by increasing prevalence of chronic disorders, increasing spending in medical research. However, concern pertaining to efficiency and proficiency of test kits hamper the growth of this market. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10725 Segment Analysis The global blood grouping reagents market is mainly segmented into product, technique, and test type, end user. On the basis of product, the blood groupin...
Read more